NCT02037945View on ClinicalTrials.gov

18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 8, 2022

Study Completion Date

December 8, 2022

Conditions
Brain Metastases
Interventions
PROCEDURE

18F-FCH PET Scan

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02037945 - 18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases | Biotech Hunter | Biotech Hunter